Burcon NutraScience Corporation (BU)

Currency in CAD
1.950
+0.090(+4.84%)
Closed·

BU Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
-0.30 / -0.09
Revenue / Forecast
1.28M / 2.4M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2026--/-0.050--/3.20M----Free Sign Up
06/2026-0.300/-0.0901.28M/2.40M-233.33%-46.67%Free Sign Up
03/2026-0.300/0.010827.00K/3.60M-3,100%-77.03%Free Sign Up
12/2025-0.280/0.010739.10K/2.90M-2,900%-74.51%Free Sign Up
09/2025-0.280/0.000357.19K/2.30M---84.47%Free Sign Up
06/2025-0.270/0.000342.19K/1.90M---81.99%Free Sign Up
03/2025-0.340/-0.00841.40K/900.00K-3,996.39%-95.4%Free Sign Up
12/2024-0.200/-0.01061.49K/500.00K-1,900%-87.7%Free Sign Up
09/2024-0.331/-0.01040.46K/600.00K-3,208%-93.26%Free Sign Up
06/2024-0.165/-0.020236.62K/656.09K-727%-63.93%Free Sign Up

All numbers in CAD

Burcon NutraScience Corporation Earnings Call Summary for Q1/2027

  • Q1 fiscal 2027 revenue hit CAD 1.3M, up 54% quarter-over-quarter and 300% year-over-year, though operating losses persist at early stage.
  • Burcon now serves 40 active customers across multiple categories; expects double-digit revenue by end of 2026 and cash flow positivity in early 2027.
  • Company plans CAD 8.1M convertible debenture offering to fund labor expansion, inventory buildup, and production capacity through Q4 fiscal 2027.
  • CEO Underwood cited production constraints as main sales limiter; management focusing resources on scaling Galesburg facility to meet growing demand.
  • Current ratio of 0.19 highlights liquidity pressure; stock rose 3.33% to $1.86, remaining 38% below 52-week high amid profitability concerns.
Last Updated: 12/08/2026, 22:42
Read Full Transcript

FAQ

What Is Burcon NutraScience's Earnings Per Share (TTM)?

The Burcon NutraScience EPS (TTM) is -1.125.

When Is The Next Burcon NutraScience Earnings Date?

Burcon NutraScience will release its next earnings report on Nov 18, 2026.

What Is Burcon NutraScience’s Revenue Forecasts For Upcoming Quarters?

Burcon NutraScience’s revenue forecast is 3.20M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.